UROTHELIAL CANCER
Clinical trials for UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody drug targets Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new drug called CT-202 in people with recurrent triple negative breast, colorectal, or urothelial cancers that have not responded to standard treatments. The drug is designed to help the immune system attack cancer cells. The main goals are to check…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Global review of bladder cancer combo therapy launches
Knowledge-focused Not yet recruitingThis study will collect and analyze data from 361 patients worldwide who received a combination of two drugs (enfortumab vedotin and pembrolizumab) as their first treatment for advanced or metastatic bladder cancer. The goal is to see how long patients live and how well the treat…
Matched conditions: UROTHELIAL CANCER
Sponsor: Aron Research Foundation Ets • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Massive bladder cancer study to reveal Real-World treatment outcomes
Knowledge-focused Not yet recruitingThis study will look at medical records from 3,000 adults with advanced bladder cancer to see how long their first treatment keeps the disease from getting worse. Researchers will also track which medicines doctors actually prescribe. This is not a new treatment trial—it simply o…
Matched conditions: UROTHELIAL CANCER
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC